J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like Why You Want to Keep This Small $2 Biotech Stock On Your Radar August 1, 2017 TrovaGene's PLK1 Inhibitor PCM-075 Demonstrates Synergy With A HDAC Inhibitor In Non-Hodgkin Lymphoma Cell Lines August 20, 2017 iCardiac Technologies Unveils An Innovative And Highly-Customizable eCOA Platform February 21, 2017
TrovaGene's PLK1 Inhibitor PCM-075 Demonstrates Synergy With A HDAC Inhibitor In Non-Hodgkin Lymphoma Cell Lines August 20, 2017
